Skip to content

Medical-device intelligence

NHX: Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

FDA product code NHX: Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NHX
FDA device name
Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
Device class
2
Regulation number
866.5775
Medical specialty
Immunology
Review panel
IM

FDA definition

The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

21 clearance records and 9 recall records in the covered releases, across 15 source company names and 1 product codes. Dated history runs from Apr 29, 2002 to Apr 24, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NHX · Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)219

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

30 matching records
Device / recordCompany in FDA recordSourceSource date
IMMUNOSCAN RA ANTI-CCP TEST SYSTEMK052133 · NHXEurodiagnostica510(k)Dec 12, 2005FDA decision date
QUANTA LITE CCP3 IGG ELISAK052264 · NHXInova Diagnostics, Inc.510(k)Nov 23, 2005FDA decision date
DIASTAT ANTI CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) ELISAK023285 · NHXAxis-Shield Diagnostics, Ltd.510(k)Oct 9, 2002FDA decision date
DIASTAT ANTI CYCLIC CITRULLINATED PEPTIDE ELISA, MODEL FCCP 200K021516 · NHXAxis-Shield Diagnostics, Ltd.510(k)Jul 23, 2002FDA decision date
QUANTA LITE CCP ELISAK020414 · NHXInova Diagnostics, Inc.510(k)Apr 29, 2002FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗